Cargando…

Combination of canagliflozin and puerarin alleviates the lipotoxicity to diabetic kidney in mice

Diabetic kidney disease is one of the most serious complications of diabetes. Although diabetic kidney disease can be effectively controlled through strict blood glucose management and corresponding symptomatic treatment, these therapies cannot reduce its incidence in diabetic patients. The sodium-g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Qian, Zhou, Qu, Luo, Xiao-li, Zhang, Xu-jie, Li, San-yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Physiological Society and The Korean Society of Pharmacology 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122997/ https://www.ncbi.nlm.nih.gov/pubmed/37078296 http://dx.doi.org/10.4196/kjpp.2023.27.3.221

Ejemplares similares

Canagliflozin attenuates lipotoxicity in cardiomyocytes and protects diabetic mouse hearts by inhibiting the mTOR/HIF-1α pathway
por: Sun, Pengbo, et al.
Publicado: (2021)

Canagliflozin Attenuates Lipotoxicity in Cardiomyocytes by Inhibiting Inflammation and Ferroptosis through Activating AMPK Pathway
por: Zhang, Wanqiu, et al.
Publicado: (2023)

The Contribution of Lipotoxicity to Diabetic Kidney Disease
por: Schelling, Jeffrey R.
Publicado: (2022)

Puerarin alleviates sleep disorders in aged mice related to repairing intestinal mucosal barrier
por: Tao, Qing, et al.
Publicado: (2023)

Puerarin Alleviates Vascular Cognitive Impairment in Vascular Dementia Rats
por: Zhu, Tiantian, et al.
Publicado: (2021)

Research on the Effect of Puerarin on Alleviating Sports Fatigue
por: Wei, Zhang
Publicado: (2015)

Effects of Puerarin Combined with PLGA/TCP/Puerarin on Osteocalcin and Sialoprotein of Mandibular Defects
por: Guo, Ying, et al.
Publicado: (2022)

Inhibition of GCN2 Alleviates Cardiomyopathy in Type 2 Diabetic Mice via Attenuating Lipotoxicity and Oxidative Stress
por: Yuan, Juntao, et al.
Publicado: (2022)

Chronopharmacokinetics of Puerarin in Diabetic Rats
por: Zhang, C. T., et al.
Publicado: (2013)

Puerarin Alleviates Neuropathic Pain by Inhibiting Neuroinflammation in Spinal Cord
por: Liu, Ming, et al.
Publicado: (2014)

Puerarin alleviates inflammation and pathological damage in colitis mice by regulating metabolism and gut microbiota
por: Zou, Yixin, et al.
Publicado: (2023)

TFEB-mediated lysosomal exocytosis alleviates high-fat diet–induced lipotoxicity in the kidney
por: Nakamura, Jun, et al.
Publicado: (2023)

Evogliptin, a DPP-4 inhibitor, prevents diabetic cardiomyopathy by alleviating cardiac lipotoxicity in db/db mice
por: Pham, Trong Kha, et al.
Publicado: (2023)

Perilipin5 protects against lipotoxicity and alleviates endoplasmic reticulum stress in pancreatic β-cells
por: Zhu, Yunxia, et al.
Publicado: (2019)

Puerarin alleviates the ototoxicity of gentamicin by inhibiting the mitochondria-dependent apoptosis pathway
por: Niu, Ping, et al.
Publicado: (2021)

Retraction Notice: Research on the Effect of Puerarin on Alleviating Sports Fatigue
por: Wei, Zhang
Publicado: (2016)

Rotten to the Cortex: Ceramide-Mediated Lipotoxicity in Diabetic Kidney Disease
por: Nicholson, Rebekah J., et al.
Publicado: (2021)

An inducible ER–Golgi tether facilitates ceramide transport to alleviate lipotoxicity
por: Liu, Li-Ka, et al.
Publicado: (2017)

Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6/ROS-dependent MAPK/NF-κB signaling pathways
por: Xiao, Long, et al.
Publicado: (2020)

Canagliflozin Improves Erythropoiesis in Diabetes Patients with Anemia of Chronic Kidney Disease
por: Maruyama, Takashi, et al.
Publicado: (2019)

Puerarin Attenuates Diabetic Nephropathy by Promoting Autophagy in Podocytes
por: Li, Xueling, et al.
Publicado: (2020)

Synergistic Hypoglycemic Effects of Pumpkin Polysaccharides and Puerarin on Type II Diabetes Mellitus Mice
por: Chen, Xue, et al.
Publicado: (2019)

Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes
por: Li, Xueling, et al.
Publicado: (2017)

Effect of Puerarin on Expression of ICAM-1 and TNF-α in Kidneys of Diabetic Rats
por: Pan, Xiaoxia, et al.
Publicado: (2015)

Fixed-dose combinations in type 2 diabetes – role of the canagliflozin metformin combination
por: Fleming, Joshua W, et al.
Publicado: (2015)

Efficacy and Safety of Canagliflozin in Kidney Transplant Patients
por: Shah, Mita, et al.
Publicado: (2019)

Molecular Mechanism of Puerarin Against Diabetes and its Complications
por: Bai, Yi-ling, et al.
Publicado: (2022)

Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?
por: Fernandez-Fernandez, Beatriz, et al.
Publicado: (2019)

Dietary Puerarin Supplementation Alleviates Oxidative Stress in the Small Intestines of Diquat-Challenged Piglets
por: Li, Meng, et al.
Publicado: (2020)

Effects of puerarin combined with conventional therapy on ischemic stroke
por: Yuan, Min, et al.
Publicado: (2017)

Lipotoxicity in Kidney, Heart, and Skeletal Muscle Dysfunction
por: Nishi, Hiroshi, et al.
Publicado: (2019)

Metabolic profile of puerarin in rats after intragastric administration of puerarin solid lipid nanoparticles
por: Luo, Cheng-Feng, et al.
Publicado: (2013)

Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease
por: Yale, J-F, et al.
Publicado: (2013)

Canagliflozin Attenuates PromarkerD Diabetic Kidney Disease Risk Prediction Scores
por: Peters, Kirsten E., et al.
Publicado: (2023)

Metformin and Canagliflozin Are Equally Renoprotective in Diabetic Kidney Disease but Have No Synergistic Effect
por: Corremans, Raphaëlle, et al.
Publicado: (2023)

Patient profiling in diabetes and role of canagliflozin
por: Amblee, Ambika
Publicado: (2014)

Prolonged diabetic ketoacidosis associated with canagliflozin
por: Sloan, Gordon, et al.
Publicado: (2018)

Lipotoxic Proximal Tubular Injury: A Primary Event in Diabetic Kidney Disease
por: Wang, Hua, et al.
Publicado: (2021)

Canagliflozin alleviates high glucose-induced peritoneal fibrosis via HIF-1α inhibition
por: Wang, Jian, et al.
Publicado: (2023)

Mesenchymal stromal cells protect hepatocytes from lipotoxicity through alleviation of endoplasmic reticulum stress by restoring SERCA activity
por: Li, Linzhao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u5aerm6q8t00ig75lvtskgqcvi